News Daily News Even With Optimized GDMT, HFrEF Prognosis Remains Dire Michael O'Riordan January 30, 2026
News Daily News Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure Michael O'Riordan December 30, 2025
News Daily News AHA Highlights Single-Pill Combo Therapy for Hypertension Todd Neale December 17, 2025
News Conference News AHA 2025 Stopping DOACs After Successful AF Ablation Feasible in Low-risk Patients: OCEAN Michael O'Riordan November 08, 2025
News Daily News High Aerobic Fitness Linked to Less Chronic Disease in Later Life Michael O'Riordan October 10, 2025
News Daily News Recognize and Enable Care for Post-MI Psychological Distress: AHA L.A. McKeown October 01, 2025
News Daily News Heart Disease Treatment Costs $100 Billion per Year in the US L.A. McKeown July 30, 2025
News Daily News Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data L.A. McKeown July 24, 2025
News Daily News AI Has Great Potential in CV Pharmacotherapy, but Much Work Lies Ahead: Review Todd Neale July 24, 2025
News Daily News Private Equity-Backed Hospitals Appear to 'Cherry-Pick' HF Patients Michael O'Riordan June 16, 2025
News Conference News ESOC 2025 ASSET-IT: Tirofiban Boosts Outcomes After IV Thrombolysis for Acute Stroke Todd Neale May 27, 2025
News Conference News European Congress on Obesity 2025 App-Based Support Aids Weight Loss With Semaglutide, Studies Show Michael O'Riordan May 13, 2025
News Daily News Access to GLP-1 Drugs Unequal for US Patients With Obesity Caitlin E. Cox May 01, 2025
News Conference News ACC 2025 FAIR-HF2: Another IV Iron Trial Fails to Impact Hard Endpoints L.A. McKeown April 03, 2025